πŸ“Š This is a profile preview from the Tablestat.com Platform Request a Free Trial Now

Valuation Trading Multiples & Precedent Transactions: Ambulatory RCM and Practice Management Software

Valuation benchmarks for Ambulatory RCM and Practice Management Software. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.

1.1 - Ambulatory RCM and Practice Management Software Market Context & Valuation Drivers

Companies in this public trading comparables group deliver cloud-based platforms that streamline ambulatory practice operations and revenue cycle management. Their core models combine subscription software with payments and RCM services to digitize patient intake, scheduling, documentation, claims, and collections. They are grouped as valuation benchmarks due to shared end markets, recurring revenue profiles, and workflow adjacency across practice management, patient engagement, and financial clearance.

Typical capabilities include electronic health records tightly integrated with practice management systems, end-to-end revenue cycle services encompassing eligibility verification, coding, claims submission, denial management, and patient billing, and front-office automation such as digital intake, online scheduling, and two-way messaging/VoIP. Many offer payment processing with card-on-file and text-to-pay, telehealth and patient portals for virtual care, and analytics dashboards that report provider productivity, collections, denial rates, and net revenue.

Primary customers are independent physician practices, multi-specialty medical groups/MSOs, and dental or other ambulatory clinics, with some adoption by health systems’ employed groups. Valuation drivers include ARR and payments volume growth, gross margin mix between SaaS and services, net revenue retention and churn, and operating efficiency metrics such as days in A/R and first-pass claim acceptance. These companies serve as public trading comparables for outpatient workflow and RCM platforms.

2. Valuation Analysis: Public Trading Comps & Multiples for Ambulatory RCM and Practice Management Software companies

2.1 - Public Peer Groups & Median Valuation Multiples for Ambulatory RCM and Practice Management Software sector

Description: Companies in this public trading comparables group deliver cloud-based platforms that streamline ambulatory practice operations and revenue cycle management. Their core models combine subscription software with payments and RCM services to digitize patient intake, scheduling, documentation, claims, and collections. They are grouped as valuation benchmarks due to shared end markets, recurring revenue profiles, and workflow adjacency across practice management, patient engagement, and financial clearance.
CompuGroup Medical logo

CompuGroup Medical

Website β€’ HQ: Germany
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of health information technology and software solutions that enhance clinical and administrative processes for healthcare providers, offering electronic health records, practice management, and revenue cycle management services to improve patient care and operational efficiency.
  • Key Products:
  • Electronic Health Records: Comprehensive solutions for managing patient records and clinical workflows
  • Practice Management: Tools for appointment scheduling, billing, and patient communication
  • Revenue Cycle Management: Services for improving financial performance and streamlining claims processing
  • Laboratory Information Systems: Software for managing laboratory operations and diagnostic data
  • Telehealth Solutions: Platforms for remote patient consultations and care delivery.
Privia Health logo

Privia Health

Website β€’ HQ: United States
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of technology-driven healthcare solutions, optimizing physician practices, enhancing patient experiences, and rewarding doctors for high-value care through collaboration with medical groups, health plans, and health systems.
  • Key Products:
  • Practice Management: Tools and services to optimize physician practices
  • Patient Portal: Platform for patient engagement and communication
  • Value-Based Care: Strategies to improve care quality and reduce costs
  • Virtual Care: Telehealth services for remote patient consultations
  • Fitness and Nutrition Plans: Personalized health assessments and plans for patients
πŸ”’
πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all 4 companies in this group
Request Free Trial Now β†’
πŸ”’
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
πŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial β†’

2.3 - Precedent M&A Transactions & Implied Enterprise Values for the Ambulatory RCM and Practice Management Software secto

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
πŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now β†’

3. Potential Strategic Acquirers for Ambulatory RCM and Practice Management Software

3.1 Top Strategic Buyers in Ambulatory RCM and Practice Management Software

πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all strategic buyers with complete profiles
Start Free Trial β†’

3.2 - Strategic Buyer Groups & Adjacent Industry and Verticals to the Ambulatory RCM and Practice Management Software sector

πŸ”’

Buyer group 1: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 2: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 3: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β†’

4. Financial Sponsors & Private Equity in Ambulatory RCM and Practice Management Software

4.1 - Buyout Funds active in Ambulatory RCM and Practice Management Software

Buyout Funds investing in Ambulatory RCM and Practice Management Software companies

50+ funds
Description: Buyout funds focused on Ambulatory RCM and Practice Management Software companies globally.

4.2 - 4.2 - Growth Capital & Late-Stage Investorsin Ambulatory RCM and Practice Management Software sector

Growth Equity Funds in Ambulatory RCM and Practice Management Software companies

40+ funds
Description: Growth equity funds focused on Ambulatory RCM and Practice Management Software companies globally.
πŸ”’ View all growth equity funds with complete profiles
Start Free Trial β†’

Valuation FAQ: Ambulatory RCM and Practice Management Software

What is the current median EV/Revenue multiple for Ambulatory RCM and Practice Management Software?

Based on our index of public trading comparables, the median Enterprise Value to Revenue (EV/Rev) multiple for the Ambulatory RCM and Practice Management Software sector is currently ●.●x. High-growth peers in the top quartile are trading at ●●.●x. View full data.

What is the average EV/EBITDA multiple for companies in this sector?

Profitable companies in the Ambulatory RCM and Practice Management Software sector trade at a median EV/EBITDA multiple of ●●.●x. This represents a change vs the 5-year historical average. Our platform tracks EBITDA multiples for Ambulatory RCM and Practice Management Software and other key peer groups.

How have valuation multiples for Ambulatory RCM and Practice Management Software trended over the last 5 years?

Valuations have adjusted since 2021. The sector saw peak multiples of ●●.●x EV/Revenue, settling to a 5-year average of ●.●x today. Access our Historical Trends chart for granular monthly data.

What are recent M&A transaction multiples in the Ambulatory RCM and Practice Management Software space?

Recent precedent transactions indicate implied enterprise values ranging from ●.●x to ●●.●x Revenue. Private market deals often trade at a liquidity discount compared to public peers. Unlock the full list of precedent transactions.

Which public companies are used as trading comps for Ambulatory RCM and Practice Management Software?

The primary trading comparable group includes Ambulatory RCM and Practice Management Software. Key constituents used for benchmarking include large-cap leaders and specialized mid-cap players. See the full list of companies in the Public Trading Comps section.

How do I value a private company in the Ambulatory RCM and Practice Management Software sector?

Valuing a private Ambulatory RCM and Practice Management Software company typically involves applying current EV/Revenue and EV/EBITDA multiples from public peers to the private company's financial metrics. A discount for lack of marketability (DLOM) of 20-30% is often applied. Our private company valuation database provides the exact multiples needed for this calculation.

What are the Ambulatory RCM and Practice Management Software industry valuation multiples for 2025?

For 2025, the Ambulatory RCM and Practice Management Software industry is trading at a median EV/Revenue multiple of ●.●x. This reflects current market sentiment, interest rates, and growth expectations. Access our platform to see how these multiples have changed from 2024 to 2025.

What is the difference between trading comps and transaction multiples for Ambulatory RCM and Practice Management Software?

Trading comps look at how public markets value similar companies today, while transaction multiples (or precedent transactions) look at the price paid in past M&A deals. Transaction multiples often include a "control premium," typically resulting in higher valuations than trading comps. Our database tracks both trading multiples and M&A transaction multiples.

Ready to Find Valuation benchmarks?

Access complete buyer lists, valuation data, and M&A intelligence for Ambulatory RCM and Practice Management Software

Launch login modal Launch register modal